Peter Ciszewski, CheckRare
Rare Disease Discussions
News and clinical perspective including CME programs focused on rare diseases. CheckRare focuses on rare and neglected diseases.
Vizitează neapărat site-ul podcastului și susține-i creatorul: www.checkrare.com
Autor
Peter Ciszewski, CheckRare
Categorie
Site-ul podcastului
Cel mai nou episod
19 nov. 2026
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
PAH Research Highlights: CHEST 2024 08.03.2025 36:40
This CME program, hosted by Jean Elwing, MD, of the University of Cincinnati College of Medicine provides an overview of the latest clinical research about PAH presented at CHEST 2024. PAH is a rare, progressive disorder characterized by high blood pressure in the pulmonary arteries. Symptoms of PAH include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting episodes...
Consider Rare: Suspecting and Diagnosing Hereditary Angioedema (HAE) 07.03.2025 24:37
Hereditary angioedema (HAE) is a rare condition often due to reduced levels C1-inhibitor, which is a protein involved in various physiological processes in plasma, most notably with the complement system. C1-inhibitor also binds and inhibits plasma kallikrein and factor XIa, thereby affecting bradykinin production. It is believed that the disruptions of these processes cause fluid to leak from the...
Improving Health Equity in Hereditary Angioedema (HAE): A Panel Discussion 27.01.2025 1:01:37
This educational program is made possible by an unrestricted grant from Takeda Pharmaceuticals. Hereditary angioedema (HAE) is a rare genetic disease that results in immunologic attacks that can be life-threatening. HAE is the result of reduced levels of C1-inhibitor, a protein involved in various physiological processes in plasma, most notably with the complement system. C1-inhibitor also binds a...
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts 18.01.2025 1:01:41
João Gonçalves Faculty of Pharmacy University of Lisbon Lisbon, Portugal Paolo Caliceti Department of Pharmaceutical and Pharmacological Sciences University of Padova Padova, Italy What Is PEGylation and Why Is It Important? We will begin by examining the clinical uses of therapeutic proteins, and their applications in healthcare. Next, we will discuss the inherent limitations of therapeutic prote...
Hematologic Malignancies and Clinical Trial Participations: A Shared Decision-Making Approach 27.11.2024 34:27
This 30-minute CME-accredited program, hosted by John Kuruvilla, MD, discusses best practices for talking to patients with hematologic malignancies about possibly participating in clinical trials. Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing education activity has been made possible through educational grant from Merck. Estimated time to comp...
FcRn and Myasthenia Gravis 07.11.2024 33:59
Jointly Provided by American Academy of CME Inc and CheckRare CE Inc. Support for this accredited continuing education activity has been made possible through an educational grant from argenx US Inc. and UCB. Estimated time to complete: 0.50 hours Start date: November 7, 2024 End date: November 6, 2025 This half-hour CME-accredited program, hosted by Richard J. Nowak, MD, MS, explains the role of...
FcRn and Myasthenia Gravis: Pathophysiology 07.11.2024 13:08
Jointly Provided by American Academy of CME Inc and CheckRare CE Inc. Support for this accredited continuing education activity has been made possible through an educational grant from argenx US Inc.and UCB. Estimated time to complete: 0.25 hours Start date: November 7, 2024 End date: November 6, 2025 This quarter-hour CME-accredited program, hosted by Richard J. Nowak, MD, MS, explains the role o...
FCRn and Myasthenia Gravis: Treatment Options 07.11.2024 20:34
Jointly Provided by the American Academy of CME and CheckRare CE Inc. Support for this accredited continuing education activity has been made possible through educational grant from argenx US Inc. and UCB. Estimated time to complete: 0.25 hours Start date: November 7, 2024 End date: November 6, 2025 This quarter-hour CME-accredited program, hosted by Richard J. Nowak, MD, MS, discusses the safety...
Cushing’s Syndrome Treatment Research Highlights: ENDO 2024Continuing Education 30.09.2024 33:04
This continuing education activity is provided by AffinityCE and CheckRare CE. This activity provides continuing education credit for physicians. A statement of participation is available for other attendees. Estimated time to complete: 0.50 hoursTo obtain CME credit, go to https://checkrare.com/learning/p-cushings-syndrome-treatment-research-highlights-endo-2024/ Commercial Support Educational Su...
CTCL: Shortening the Diagnostic Journey and Starting Treatment Early 30.09.2024 19:51
Yuliya Linhares, MD is a medical oncologist specializing in the comprehensive treatment of lymphoma and serves as chief of Lymphoma Services at Miami Cancer Institute. In this video, Dr. Linhares provides an overview of cutaneous T-cell lymphoma (CTCL) and discusses some strategies for shortening the diagnostic journey of this rare cancer. The diagnosis of CTCL is often challenging; as a result, d...
CTCL: The Role of Dermatologists in Diagnosing and Caring for Patients 26.07.2024 12:54
Larisa Geskin, MD, Professor of Dermatology at Columbia University Medical Center and Director of the Comprehensive Skin Cancer Center at the Division of Cutaneous Oncology in the Department of Dermatology, discusses the challenges of diagnosing cutaneous T-cell lymphoma (CTCL). The diagnosis of CTCL is often challenging; as a result, delays in diagnosis (and subsequently work-up and treatment) ca...
Myasthenia Gravis Research Highlights: AAN 2024 17.06.2024 25:28
Jointly Provided by American Academy of CME and CheckRare CE. Supported by educational grants from argenx US, Inc. and UCB Inc. To claim credit for this program, please visit https://checkrare.com/learning/p-myasthenia-gravis-research-highlights-aan-2024/ Estimated time to complete: 0.5 hours Start date: June 15, 2024 End date: June 30,2025 Activity Description This accredited CME program highligh...
Fabry Disease From a Patient’s Perspective, Featuring Maya Kineen 08.06.2024 15:14
In this episode of our series focused on Fabry disease, we feature Maya Kineen, a patient and advocate with this rare disorder. Fabry disease is an inherited disorder that results from the buildup of a particular type of fat, called globotriaosylceramide, in the body's cells. Beginning in childhood, this buildup causes signs and symptoms that affect many parts of the body. Characteristic features...
Signs and Symptoms of Fabry Disease, Featuring Nicola Longo, MD 08.06.2024 24:35
This is the second of a three-part series focusing on Fabry disease. In this episode, we talk with Nicola Longo, MD, Chief of the Division of Medical Genetics at the University of Utah, Spencer Fox Eccles School of Medicine in Salt Lake City. Dr. Longo discusses Fabry disease, including the progression of the disease and personalized medicine. Fabry disease is an inherited disorder that results fr...
Fabry Disease Overview, Featuring William Burns, MD 08.06.2024 24:28
In this first part of our four-part series on Fabry disease, we feature William Burns, MD, a biochemical geneticist at Greenwood Genetic Center in Greenwood, South Carolina. Dr. Burns summarizes this rare disease, including current management strategies. Fabry disease is a lysosomal storage disorder, meaning that a glycosphingolipid called GL-3 accumulates in the lysosomes, causing tissue damage;...
Kidney Involvement in Lysosomal Disorders 05.03.2024 1:00:00
Ozlem Goker-Alpan, MD, Founder and President, LDRTC and David G. Warnock, MD. Professor of Medicine (Emeritus) at University of Alabama at Birmingham discuss best practices to identify and treat kidney problems associated with lysosomal disorders. This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with kidney problems. This continuing educati...
HAE Treatment Advances: Highlights from ACAAI 03.03.2024 16:03
This 16-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the future treatment options for patients with hereditary angioedema (HAE) presented at ACAAI 2023. Jointly Provided by American Academy of CME and CheckRare CE. Support for this...
Hereditary Angioedema: Current Treatment Options 03.03.2024 24:43
This 25-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the current treatment options for patients with hereditary angioedema (HAE). Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing...
Assessing, Monitoring, and Managing Respiratory Involvement in Lysosomal Disorders 03.03.2024 51:44
Ozlem Goker-Alpan, MD of LDRTC and John Bach, MD, Professor of Neurology at Rutgers School of Medicine discuss best practices to manage respiratory complications in persons with lysosomal disorders. This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides...
Hereditary Angioedema: Current and Future Treatment Options 31.01.2024 40:16
This 40-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the current and future treatment options for patients with hereditary angioedema (HAE). Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited...
Alpha-Mannosidosis From a Mom’s Perspective, Featuring Rhonda Skipper 20.12.2023 10:27
In this final episode of our four-part series focused on alpha-mannosidosis, we feature Rhonda Skipper, a mom of two boys, Dale and Matt, who have this rare disease. Alpha-mannosidosis is a rare genetic disorder characterized by a deficiency of the enzyme alpha-D-mannosidase. Alpha-mannosidosis is best thought of as a continuum of disease that is generally broken down into three forms: a mild, slo...
Diagnosing and Managing Alpha-Mannosidosis, Featuring Markey McNutt, MD, PhD 20.12.2023 13:16
This is the third of a four-part series focusing on alpha-mannosidosis. In this episode, we feature Dr. Markey McNutt, who will focus on the challenges of identifying and caring for patients with this rare disease. Dr. McNutt is a Clinical Geneticist at the University of Texas Southwestern Medical Center in Dallas. Alpha-mannosidosis is a rare genetic disorder characterized by a deficiency of the...
Signs and Symptoms of Alpha-Mannosidosis, Featuring Reid Sutton, MD 20.12.2023 16:12
This is the second of a four-part series focusing on alpha-mannosidosis. In this episode, we talk with Dr. Reid Sutton on the challenges of recognizing this rare disease, focusing on the signs and symptoms. Dr. Sutton is a Clinical Geneticist and a Clinical Biochemical Geneticist at Baylor College of Medicine and Texas Children’s Hospital in Houston. Alpha-mannosidosis is a rare genetic disorder c...
Alpha-Mannosidosis Overview, Featuring Laura Buch, MSPAS, PA-C 20.12.2023 28:09
In this first part of our four-part series on alpha-mannosidosis, we feature Laura Buch, a physician assistant who practices medical genetics at the Greenwood Genetic Center in South Carolina. Laura’s work focuses on the diagnosis and treatment of patients with abnormal newborn screens, inborn errors of metabolism, and lysosomal storage disorders. She also cares for alpha-mannosidosis patients. Al...
Myasthenia Gravis and the Complement System: Treatment Options 19.12.2023 27:05
This 30-minute CME-accredited program highlights the connection between the complement system and myasthenia gravis in regards to the treatment of this rare disease. Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing education activity has been made possible through educational grant from UCB. Start date: December 18, 2023. End date: December 18, 2...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice